| Literature DB >> 29298096 |
Cheng Gu1, Cheng Chen2, Ruipeng Wu1, Tong Dong1, Xiaojuan Hu1, Yuping Yao1, Yi Zhang1.
Abstract
Alzheimer's disease (AD) is the most common form of dementia; its pathophysiological mechanism remains unclear. Long noncoding RNAs (lncRNAs) play key roles in AD. lncRNA EBF3-AS has been found dysregulated in AD, which is abundantly expressed in the brain. The aim of this study was to investigate the role of EBF3-AS in AD. Results showed that the expressions of lncRNA EBF3-AS and EBF3 (early B cell factor 3) were upregulated in hippocampus of APP/PS1 mice (AD model mice). EBF3-AS knockdown by siRNA inhibited the apoptosis induced by Aβ25-35 and okadaic acid (OA) in SH-SY5Y. The expression of EBF3 was downregulated in Aβ25-35- and OA-treated SH-SY5Y, which was reversed by EBF3-AS knockdown. EBF3 knockdown can reverse the Aβ25-35-induced apoptosis in SH-SY5Y. These results revealed that lncRNA EBF3-AS promoted neuron apoptosis in AD, and involved in regulating EBF3 expression. EBF3-AS may be a new therapeutic target for treatment of AD.Entities:
Keywords: Alzheimer's disease; SH-SY5Y; lncRNA EBF3-AS; neurons apoptosis
Mesh:
Substances:
Year: 2018 PMID: 29298096 DOI: 10.1089/dna.2017.4012
Source DB: PubMed Journal: DNA Cell Biol ISSN: 1044-5498 Impact factor: 3.311